{
  "pmcid": "6233790",
  "abstract": "1. A 250-word version\n\nTitle: Randomised Controlled Trial of VTE Prophylaxis in Korean Patients Undergoing Gastrectomy\n\nBackground: Thromboprophylaxis is recommended for gastric adenocarcinoma patients, but its use is less common in Asia due to perceived lower VTE incidence.\n\nMethods: This randomised controlled trial was conducted at Seoul St Maryâ€™s Hospital, South Korea, from August 1, 2011, to March 31, 2015. Patients with histologically confirmed gastric adenocarcinoma were randomised to receive either intermittent pneumatic compression (IPC) alone or IPC plus low-molecular-weight (LMW) heparin sodium. Randomisation was performed using a computer-generated sequence with allocation concealment. The primary outcome was VTE incidence within the postoperative period. Secondary outcomes included postoperative complications related to VTE prophylaxis. Blinding was not applied.\n\nResults: A total of 682 patients were randomised, with 341 in each group. The analysis included 666 patients, using both intention-to-treat and per-protocol approaches. VTE incidence was 3.6% in the IPC-only group and 0.6% in the IPC+LMW heparin group (P = .008). Bleeding complications occurred in 9.1% of the IPC+LMW heparin group and 1.2% of the IPC-only group (P < .001). No VTE-associated mortality was observed.\n\nInterpretation: IPC alone is less effective than IPC+LMW heparin in preventing postoperative VTE, but LMW heparin increases bleeding risk. Further research is needed to identify patients at high risk for VTE.\n\nTrial Registration: ClinicalTrials.gov Identifier: NCT01448746\n\nFunding: Not specified.",
  "word_count": 221
}